SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tommysdad who wrote (5262)9/4/1998 1:23:00 PM
From: Peter Church   of 6136
 
I think you can't take agph's fall too personally. It's just sinking with the tide. McCamant mentions several other biotechs which have done worse but have excellent prospects: isip, axph, imcl, icos.

Does anyone follow McCamant and have a sense of his stock picking ability? He also says that biotechs are not cyclical. But, how are some of these unprofitable companies going to survive if capital gets scarce? By being swallowed by larger fish, I guess.

bioinvest.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News